(Q51971601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

The added therapeutic efficacy and safety of alefacept in combination with other (systemic) anti-psoriatics in refractory psoriasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Annechien M G Langewouters

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Elke M G J De Jong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Peter C M Van De Kerkhof

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

Journal of Dermatological Treatment

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

362-369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630601028794

Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601028794

Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601028794

Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601028794

Alefacept for the treatment of psoriasis: a review of the current literature and practical suggestions for everyday clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601028794

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601028794

Combining traditional agents and biologics for the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601028794

Alefacept therapy produces remission for patients with chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601028794

10.1080/09546630601028794

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17853311%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference